Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief ...
Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD
Source: kulr8.com
📰 Macusight Inc News
Macusight Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Macusight Inc. Real-time updates on events, politics, business and more.